Tg Therapeutics Inc (TGTX)

Cost of Revenue

$41.19M

Quarterly · Period ending: · USD

TGTX logo

TGTX Cost of Revenue

Latest reported$41.19M
TGTX Quarterly Cost of Revenue ($0.00 → $41.19M)
High-resolution chart · PNG

TGTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
295,316
2,055,625
1,375,000
839,373
1,130,735
714,228
700,000
200,000
0
0
-100,000
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.